Modernizing the Purification Toolbox for Multi-Specific Antibodies, CRISPR and Cell and Gene Therapies
Harvest time has come for modern biotechnology and biotherapeutics, bringing a cornucopia of products – CRISPR Cas nucleases, therapeutic viruses, cells and engineered tissue constructs.
Along with superior therapeutic efficacy, these products feature unprecedented complexity of biomolecular features and range of scales that define their identity, efficacy and safety.
In this webinar, our expert speaker Dr. Stefano Menegatti from NC State University, will discuss his team’s approach in leveraging affinity technology to introduce new tools for purifying and characterizing biotherapeutics to match the growing demands of clinics and biotech industries worldwide.
Attend this webinar to:
- Learn about affinity ligands operating in negative and positive capture mode for the continuous purification of biotherapeutics
- Discover first of its kind RNA triggers for the purification of CRIPSR-CAS nucleases via affinity chromatography
- Explore the complexity of EIS sensors for one-step quantification of total virus particle and empty capsid quantification
Presenter: Stefano Menegatti, PhD (Associate Professor, Chemical and Biomolecular Engineering, NC State University)
